Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs150097723 | chr2:118683279 | G/A | 1.6E-5 | 178 | 25.17 | 30.93 | 11.65 | KM Plot |
PCPG | rs150100638 | chr7:33698283 | C/T | 1.26E-7 | 176 | 25.17 | 25.43 | 19.87 | KM Plot |
PCPG | rs150291879 | chr2:242559719 | G/A | 2.92E-5 | 175 | 25.87 | 26.47 | 20.28 | KM Plot |
PCPG | rs1503041 | chr17:50294496 | A/G | 6.08E-5 | 178 | 25.67 | 27.95 | 14.47 | KM Plot |
PCPG | rs1503042 | chr17:50294376 | C/T | 6.66E-5 | 177 | 25.77 | 27.95 | 14.47 | KM Plot |
PCPG | rs150331379 | chr7:105163809 | C/T | 5.36E-5 | 177 | 20.2 | 30.45 | 2.28 | KM Plot |
PCPG | rs150528227 | chr20:5996831 | A/AG | 0 | 178 | 25.47 | 23.53 | 2.93 | KM Plot |
PCPG | rs150638279 | chr3:53426450 | T/TAG | 0.000209 | 176 | 25.28 | 31.9 | 26.73 | KM Plot |
PCPG | rs150763895 | chr8:53841491 | T/TCAAA | 0.000414 | 174 | 24.47 | 27.2 | 6.1 | KM Plot |
PCPG | rs150842083 | chr7:105162366 | GACC/G | 5.12E-5 | 178 | 20.2 | 29.43 | 2.28 | KM Plot |
PCPG | rs150856057 | chr10:69599615 | G/T | 0 | 173 | 25.87 | 18.2 | 2.28 | KM Plot |
PCPG | rs150931789 | chr12:56678335 | T/C | 9.63E-8 | 178 | 25.35 | 27.33 | 0.8 | KM Plot |
PCPG | rs150955176 | chr12:56706421 | T/C | 1.01E-7 | 177 | 25.35 | 29.13 | 0.8 | KM Plot |
PCPG | rs151105710 | chr3:136125678 | G/GATTAAAGA | 4.45E-5 | 172 | 25.27 | 28.3 | 24.1 | KM Plot |
PCPG | rs151131396 | chr10:102308822 | C/T | 9.39E-6 | 170 | 24.1 | 28.93 | 25.17 | KM Plot |